It reads to me that actual Ethics Committee submission won't be until Q2 because they will commence engagement in Q1; then the Ethics process takes at least 6 weeks so Phase I trials will start in Q3; therefore Phase I trials unlikely to be complete in calendar 2022
Ann: Preliminary Pre-Clinical Tox Studies Successfully Completed, page-20
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $81.06M | |||
| Open | High | Low | Value | Volume |
| 66.5¢ | 66.5¢ | 65.0¢ | $63.22K | 96.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11631 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 17492 | 1 |
View Market Depth
| Last trade - 12.31pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
66.5¢ |
Change
0.000 ( 0.76 %) |
||||
| Open | High | Low | Volume | ||
| 65.5¢ | 66.5¢ | 65.0¢ | 37855 | ||
| Last updated 12.28pm 14/05/2024 ? | |||||
| AGN (ASX) Chart |